VOOZH about

URL: https://pubmed.ncbi.nlm.nih.gov/33971376/

⇱ Application of an evidence-based, out-patient treatment strategy for COVID-19: Multidisciplinary medical practice principles to prevent severe disease - PubMed


Clipboard, Search History, and several other advanced features are temporarily unavailable.
Skip to main page content
πŸ‘ Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

πŸ‘ Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Abstract

The COVID-19 pandemic has devastated individuals, families, and institutions throughout the world. Despite the breakneck speed of vaccine development, the human population remains at risk of further devastation. The decision to not become vaccinated, the protracted rollout of available vaccine, vaccine failure, mutational forms of the SARS virus, which may exhibit mounting resistance to our molecular strike at only one form of the viral family, and the rapid ability of the virus(es) to hitch a ride on our global transportation systems, means that we are will likely continue to confront an invisible, yet devastating foe. The enemy targets one of our human physiology's most important and vulnerable life-preserving body tissues, our broncho-alveolar gas exchange apparatus. Notwithstanding the fear and the fury of this microbe's potential to raise existential questions across the entire spectrum of human endeavor, the application of an early treatment intervention initiative may represent a crucial tool in our defensive strategy. This strategy is driven by evidence-based medical practice principles, those not likely to become antiquated, given the molecular diversity and mutational evolution of this very clever "world traveler".

Keywords: Alveoli; Bronchiole; Budesonide; COVID-19; Dexamethasone; Expectorate; Gas exchange; Inflammation; L-albuterol; Methotrexate; Mucus clearance; Oxygen saturation; Postural percussion; Pulmonary hygiene; Pulse oximetry; Respiratory muscle training; SARS-CoV-2; Vibratory sonication; Vitamin D.

PubMed Disclaimer

Figures

πŸ‘ Unlabelled Image
(Click here) ()
πŸ‘ Fig. 1
Fig. 1
All steps are taken for a total of 10 days. [Numbers Correspond to those in Fig. 1]
πŸ‘ Fig. 2
Fig. 2
Pathophysiology of severe COVID-19 from mild/moderate COVID-19 and the mechanistic treatment for its prevention.
πŸ‘ None
πŸ‘ None
πŸ‘ None
πŸ‘ None
πŸ‘ None
πŸ‘ None
πŸ‘ None
πŸ‘ None
πŸ‘ None

References

    1. Razonable R.R., Pennington K.M., Meehan A.M., Wilson J.W., Froemming A.T., Bennett C.E., Marshall A.L., Virk A., Carmona E.M. A collaborative multidisciplinary approach to the management of coronavirus disease 2019 in the hospital setting. Mayo Clin. Proc. 2020 Jul;95(7):1467–1481. doi: 10.1016/j.mayocp.2020.05.010. Epub 2020 May 30. PMID: 32622450; PMCID: PMC7260518. - DOI - PMC - PubMed
    1. Frohman E.M., Villemarette-Pittman N.R., Melamed E., Cruz R.A., Longmuir R., Varkey T.C., Steinman L., Zamvil S.S., Frohman T.C. Part I. SARS-CoV-2 triggered β€˜PANIC’ attack in severe COVID-19. J. Neurol. Sci. 2020 Aug 15;415 doi: 10.1016/j.jns.2020.116936. 116936. Epub 2020 May 21. PMID: 32532449; PMCID: PMC7241348. - DOI - PMC - PubMed
    1. Shaw J.G., Sankineni S., Olaleye C.A., Johnson K.L., Locke J.L., Patino J., Sabi F.L., McCarthy R.J. A novel large scale integrated telemonitoring program for COVID-19. Telemed. J. e-Health. 2021 Feb 5 doi: 10.1089/tmj.2020.0384. 33544043 Epub ahead of print. - DOI - PubMed
    1. Blair P.W., Brown D.M., Jang M., Antar A.A.R., Keruly J.C., Bachu V.S., Townsend J.L., Tornheim J.A., Keller S.C., Sauer L., Thomas D.L., Manabe Y.C., Ambulatory COVID Study Team The clinical course of COVID-19 in the outpatient setting: a Prospective Cohort Study. Open Forum Infect. Dis. 2021 Jan 5;8(2) doi: 10.1093/ofid/ofab007. ofab007. PMID: 33614816; PMCID: PMC7881750. - DOI - PMC - PubMed
    1. Browne S.H., Bernstein M., Pan S.C., Gonzalez Garcia J., Easson C.A., Huang C.C., Vaida F. Smartphone biosensor with app meets FDA/ISO standards for clinical pulse oximetry and can be reliably used by a wide range of patients. Chest. 2021 Feb;159(2):724–732. doi: 10.1016/j.chest.2020.08.2104. Epub 2020 Sep 11. PMID:32926871; PMCID: PMC7485544. - DOI - PMC - PubMed
Cite

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.